Literature
Multimodality Imaging of Giant Coronary Aneurysm and Spontaneous Thrombosis With Left Coronary Artery-Right Atrium Fistula.
Signal observed of a giant coronary aneurysm with spontaneous thrombosis and left coronary artery-right atrium fistula requiring surgical intervention due to high-risk complications including thrombosis and atrial fibrillation. Evidence suggests coronary artery fistulas most commonly involve the right coronary artery (55%) followed by left coronary artery (35%), typically draining into right atrium or pulmonary artery. Worth noting that while often asymptomatic, large shunt volumes can present with myocardial ischemia, heart failure, and arrhythmias.
Given the presence of high-risk factors such as aneurysm rupture, thrombosis, and atrial fibrillation (AF), surgical intervention was performed on this patient.
Relevance: Coronary artery complications are relevant to Kawasaki disease sequelae and complex congenital heart disease management in pediatric cardiology practice.
PMID: 41915120Echocardiography (Mount Kisco, N.Y.)(Case Reports) Literature
Underuse of Guideline-Directed Medical Therapy Across Heart Failure Phenotypes in Older Outpatients: A Multicenter Cross-Sectional Study in Vietnam.
Evidence suggests significant underuse of guideline-directed medical therapy in heart failure patients, with 49.8% of HFrEF and 38.0% of non-HFrEF patients not receiving optimal treatment. Signal observed that hypertension was associated with better GDMT use in HFrEF (OR 0.38), while COPD was associated with greater underuse (OR 4.42). Worth noting that diabetes mellitus was independently associated with lower GDMT underuse in non-HFrEF phenotypes (OR 0.52).
In HFrEF, hypertension was associated with lower GDMT underuse and COPD with higher GDMT underuse, whereas in non-HFrEF, diabetes mellitus was independently associated with lower...
Relevance: Study provides real-world data on heart failure medication utilization patterns including ACE inhibitors and beta-blockers that are relevant to heart failure research interests.
PMID: 41914698Journal of cardiovascular pharmacology and therapeutics(Journal Article) Literature
Conduction System Pacing Versus Biventricular Cardiac Resynchronization in HFmrEF: A Systematic Review and Meta-Analysis.
Evidence suggests conduction system pacing may be superior to biventricular pacing in heart failure with mildly reduced ejection fraction, reducing heart failure hospitalizations (HR 0.63) and composite death/hospitalization outcomes (HR 0.64). Signal observed of greater QRS narrowing with CSP (14 ms improvement) and consistent trends toward functional improvement. Worth noting that device-related complications were numerically lower with conduction system pacing approaches.
Large randomized trials are warranted to confirm these findings and establish CSP as a standard resynchronization strategy.
Relevance: Meta-analysis addresses heart failure management strategies and resynchronization therapy relevant to heart failure research interests.
PMID: 41902448Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc(Journal Article) Literature
Aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) for preventing colorectal cancer and colorectal adenoma in the general population.
Evidence suggests aspirin may reduce colorectal cancer incidence slightly at ≥15 years follow-up (HR 0.78) but shows little to no difference at shorter intervals. Signal observed of increased serious extracranial hemorrhage risk (RR 1.59) and probable increased hemorrhagic stroke risk (OR 1.40) with aspirin use. Worth noting the complex time-dependent effects with potential early increase in CRC mortality at 5-10 years but possible long-term mortality reduction.
Protocol available via doi.org/10.1002/14651858.CD015266.
Relevance: While aspirin is in the practice formulary, this focuses on cancer prevention rather than cardiovascular indications relevant to pediatric cardiology.
PMID: 41919561The Cochrane database of systematic reviews(Journal Article) Literature
Pulsed field ablation for atrial fibrillation in patients with heart failure: insight from the ATHENA registrys.
Evidence suggests pulsed field ablation achieved 79.9% freedom from atrial arrhythmias at 1-year, with lower success rates in heart failure patients (73.3%) compared to those without HF (81.0%, HR 1.5). Signal observed of particularly notable differences in paroxysmal AF, where HF patients had 68.6% success versus 82.2% in non-HF patients. Worth noting that persistent AF showed similar outcomes regardless of heart failure status (77.9% vs 76.4%).
URL: http://clinicaltrials.gov/Identifier: NCT05617456.
Relevance: Study addresses arrhythmia management in heart failure patients, relevant to heart failure research interests and complex cardiac conditions.
PMID: 41910215Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology(Journal Article) Literature
Efficacy comparison of dapagliflozin combined with liraglutide versus monotherapy in obese patients with heart failure.
Signal observed that combination dapagliflozin and liraglutide showed greater improvement in BNP levels and 6-minute walk distance compared to monotherapy in obese HFpEF patients. Evidence suggests synergistic effects on weight loss and glucose control with the combination approach. Worth noting lower incidence of major cardiovascular composite endpoints in the combination group with similar adverse event rates across treatment arms.
Dapagliflozin combined with liraglutide has a synergistic effect in improving cardiac function and metabolic disorders in obese patients with HFpEF, with good safety, providing a...
Relevance: Addresses heart failure treatment strategies relevant to heart failure research interests, though involves medications not in the current formulary.
PMID: 41894290Medicine(Journal Article) Literature
PRIME-HFrEF Trial: a randomized, double-blind, multi-dose umbilical cord-derived mesenchymal stem cell regimen for heart failure.
Evidence suggests multi-dose umbilical cord-derived mesenchymal stem cells were safely administered to HFrEF patients with significant improvement in right ventricular end-systolic volume compared to placebo. Signal observed of elevated D-dimer levels indicating increased coagulability with UC-MSC treatment, which negatively correlated with LVEF. Worth noting that despite RV volume improvements, no significant difference in left ventricular ejection fraction change was observed between groups.
However, these benefits were accompanied by transient increases in coagulability, which may have attenuated potential improvements in left ventricular contractile function.
Relevance: Clinical trial directly addresses heart failure with reduced ejection fraction treatment, relevant to heart failure research interests.
PMID: 41888108Signal transduction and targeted therapy(Journal Article)